1 |
Agboola OO, Grunfeld E, Coyle D, Perry GA (1997). Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ, 157, 879-86.
|
2 |
Berchuck A, Anspach C, Evans AC, et al (1995). Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol, 59, 20-4.
DOI
|
3 |
Burke WM, Orr J, Leitao M, et al (2014). Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol, 134, 393-402.
DOI
|
4 |
Burke WM, Orr J, Leitao M, et al (2014). Endometrial cancer: a review and current management strategies: part I. Gynecol, 134, 385-92.
|
5 |
Cragun JM, Havrilesky LJ, Calingaert B, et al (2005). Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol, 23, 3668-75.
DOI
|
6 |
Demiral S, Beyzadeoglu M, Sager O, et al (2014). Evaluation of treatment outcomes of early-stage endometrial cancer radiotherapy: a single center experience. Asian Pac J Cancer Prev, 15, 9599-602.
DOI
|
7 |
Hidaka T, Nakamura T, Shima T, Yuki H, Saito S (2006). Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma. J Obstet Gynaecol Res, 32, 330-7.
DOI
|
8 |
Huang HJ, Tang YH, Chou HH, et al (2014). Treatment failure in endometrial carcinoma. Int J Gynecol Cancer, 24, 885-93.
DOI
|
9 |
Jamison PM, Noone AM, Ries LA, Lee NC, Edwards BK (2013). Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev, 22, 233-41.
DOI
|
10 |
Krusun S, Pesee M, Rasio W, et al (2014). Survival rate of early stage endometrioid adenocarcinoma of endometrium treated at Srinagarind Hospital. Asian Pac J Cancer Prev, 15, 2217-20.
DOI
|
11 |
Morrow CP, Bundy BN, Kurman RJ, et al (1991). Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol, 40, 55-65.
DOI
|
12 |
Siegel RJ, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29.
DOI
|
13 |
Panggid KC, Cheewakriangkrai C, Khunamornpong S, Siriaunkgul S (2010). Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma. J Obstet Gynaecol Res, 36, 1044-8.
DOI
|
14 |
Podczaski E, Kaminski P, Gurski K, et al (1992). Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol, 47, 323-7.
DOI
|
15 |
Setakornnukul J, Petsuksiri J, Wanglikitkoon S, et al (2014). Long term outcomes of patients with endometrial carcinoma treated with radiation - Siriraj Hospital experience. Asian Pac J Cancer Prev, 15, 2279-85.
DOI
ScienceOn
|
16 |
Sohaib SA, Houghton SL, Meroni R, et al (2007). Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol, 62, 28-34.
DOI
|
17 |
Sovak MA, Hensley ML, Dupont J, et al (2006). Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study. Gynecol Oncol, 103, 451-7.
DOI
|